BioSenic provides update regarding current license agreement with Phebra

INSIDE INFORMATION Maintenance of the license isnow subject to the launch of the OATO Phase III before May 2024instead of 31 May 2023 Parties also…

Related Keywords

Belgium ,Paris ,France General ,France ,Australia ,Mont Saint Guibert ,Waals Gewest ,Canada ,Australians ,Belgian ,French ,Australian ,Seitosei Actifin ,Neil Hunter Michelle Boxall ,Annie Florence Loyer ,Bert Bouserie ,Ghislaine Gasparetto ,Biosenic Group ,International Media Enquiries ,Ib Communications ,Phebra Pty Ltd ,Euronext Brussels ,Graft Versus Host Disease ,Systemic Sclerosis ,Systemic Lupus Erythematosus ,Medsenic Territories ,Chief Executive Officer ,South Americas ,Arsenic Trioxide ,Host Disease ,Louvain La Neuve Science Park ,Mesenchymal Stromal Cells ,Systemic Lupus ,Chief Executive ,Belgian Media ,Investor Enquiries ,French Media Enquiries ,French Investor Enquiries ,Biosenic ,Provides ,Update ,Regarding ,Current ,License ,Agreement ,Phebra ,